We are live on
!
Find out more
DC
DPM Capital Portfolio holdings
AUM
$78.7M
1-Year Est. Return
2.71%
This Fund
S&P 500
This Quarter
Est. Return
-0.15%
1 Year Est. Return
-2.71%
3 Year Est. Return
+109.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$54.3M
(-31%)
Cap. Flow
-$54.7M
Cap. Flow
% of AUM
-46.09%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
–
Reduced
1
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacira BioSciences
PCRX
|
+$7.75M |
| 2 |
Axalta
AXTA
|
+$5.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$19.5M |
| 2 |
Wells Fargo
WFC
|
+$19.3M |
| 3 |
Packaging Corp of America
PKG
|
+$16.2M |
| 4 |
Delta Air Lines
DAL
|
+$7.93M |
| 5 |
Synchrony
SYF
|
+$4.84M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 72.36% |
| 2 | Financials | 23.08% |
| 3 | Materials | 4.56% |
| 4 | Consumer Discretionary | 0% |
| 5 | Industrials | 0% |
Similar funds
BCM
LMAM
MTM
SCC
CG1
VIA
BBCM
ST
DPM Capital's Q3 2019 Portfolio in Review
As of Q3 2019, DPM Capital held 8 positions worth $119M, down 31% from $173M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
DPM Capital withdrew a net $54.7M in Q3 2019, closing 4 positions and reducing 1 holding. Its most notable exit was Goldman Sachs, an estimated $19.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 72% of assets, up from 45% a quarter earlier, followed by Financials and Materials.
Against the trend, DPM Capital opened a new position in Pacira BioSciences worth $7.4M.
- DPM Capital's largest Q3 2019 buy was Pacira BioSciences: 194,262 shares worth $7.4M.
- DPM Capital's biggest Q3 2019 reduction was Synchrony, cutting an estimated $4.84M.
- DPM Capital fully exited Goldman Sachs in Q3 2019, selling an estimated $19.5M.
- DPM Capital's ten largest holdings make up 100% of its $119M portfolio in Q3 2019.
- DPM Capital opened 2 new positions and closed 4 in Q3 2019.
- DPM Capital's portfolio value fell 31% quarter-over-quarter to $119M.
Based on DPM Capital's 13F filing for Q3 2019, filed 30 Oct 2019.